Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Banks pocketed huge sums in the first quarter from equities because the “increased market volatility” triggered a rush on transactions.
As a share of US GDP, the manufacturing sector has decreased from a nearly 25% peak in the 1950s to about 11% today.
A handful of retail executives hinted this week that they are eyeing some strategic advantages and opportunities amid the trade war.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
It seems quality never goes out of style for Levi Strauss, even amid a a tariff-induced global financial meltdown.
A Minecraft Movie is lighting the box office on fire. It’s a much-needed win for the battered Warner Bros Discovery.
Airline stocks are in a prolonged nosedive: Delta, American, and United have each fallen 35 to 45% this year.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The high court’s ruling effectively bans flavored vape products because of concerns that they could appeal to kids.
The contestants in Washington’s long-running game show are now known, we think. And Hollywood is nowhere to be seen.
A talent shortage, increasing regulatory scrutiny, and technological advancements are straining the accounting industry.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.